Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Effect of Curd Cheese on Metabolic Health in Adults

27 juni 2026 uppdaterad av: Süleyman Kılıç

The Effect of a Diet Intervention Supplemented With Curd Cheese on Anthropometric Measurements, Glycemia, and Lipidemia in Adults Applying to Darıca Healthy Life Center

This randomized controlled trial aims to evaluate the effects of a diet supplemented with curd cheese on anthropometric measurements, glycemia, and lipid profile in overweight adults. Participants aged 40-64 years with a BMI above 25 will be randomly assigned to an intervention group receiving 100 g of curd cheese at breakfast for 8 weeks or to a control group receiving a standard healthy diet without curd cheese. Primary outcomes include changes in fasting blood glucose and HbA1c, while secondary outcomes are changes in body composition, waist circumference, and lipid profile (HDL, LDL, triglycerides, total cholesterol).

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Metabolic disorders, including obesity, dyslipidemia, and type 2 diabetes mellitus, are major public health concerns worldwide. Dietary protein quality and source have been shown to play important roles in regulating glucose and lipid metabolism. Whey-derived proteins are rich in branched-chain amino acids and bioactive peptides that may enhance insulin sensitivity, promote satiety, and improve lipid profiles.

Curd cheese (lor cheese) is a traditional dairy product obtained during whey processing, characterized by its high-quality protein, low fat content, and rich calcium composition. It represents an affordable and accessible food that could be incorporated into dietary interventions targeting metabolic health improvement.

This study aims to investigate the effects of a curd cheese-supplemented diet on anthropometric parameters, glycemic control (including fasting glucose and HbA1c), and lipid profile (total cholesterol, HDL, LDL, and triglycerides) in adults attending the Darıca Healthy Life Center. Participants will follow a controlled dietary intervention with or without curd cheese for eight weeks.

The hypothesis of this study is that regular consumption of curd cheese as part of a balanced diet may improve metabolic parameters through increased protein intake, better glycemic regulation, and enhanced lipid metabolism.

Studietyp

Interventionell

Inskrivning (Faktisk)

44

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

  • Turkiet (Türkiye)
    • DARICA
      • Kocaeli, DARICA, Turkiet (Türkiye), 41700
        • Darıca Healthy Life Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Individuals aged 40-64 years.
  • Body Mass Index (BMI) greater than 25 kg/m².
  • Individuals who voluntarily applied to the Darıca Healthy Life Center and agreed to participate in the study.
  • Individuals who have had HbA1c, glucose, and lipid profile measurements within the past month, or will have these measurements taken as part of this study.
  • Individuals who are able to comply with the curd cheese-supplemented dietary intervention for at least 8 weeks.
  • Individuals who have signed the written informed consent form.

Exclusion Criteria:

  • Individuals diagnosed with diabetes mellitus.
  • Individuals with chronic diseases such as renal, hepatic, or cardiac failure.
  • Individuals with lactose intolerance or allergy to milk and dairy products.
  • Pregnant or lactating women.
  • Individuals with restricted protein intake for any medical reason.
  • Individuals who have participated in another dietary intervention program within the last 3 months.
  • Individuals diagnosed with psychiatric disorders requiring regular treatment.
  • Individuals with irregular lifestyles or communication difficulties that may prevent adherence to the dietary intervention.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Curd Cheese Supplemented Diet Group

Intervention Group - Arm Description:

Participants in this arm follow a customized dietary plan for 8 weeks that includes daily servings of curd cheese. The diet is balanced for energy and macronutrient distribution according to individual needs. Curd cheese, as a high-quality protein and calcium source, is included to assess its specific effects on glucose and lipid parameters. This arm is designed to evaluate the unique metabolic effects of curd cheese supplementation compared to the control group.
Kosttillskott: Curd Cheese Supplemented Diet
This intervention consists of daily consumption of 100 grams of curd cheese as part of a personalized dietary plan for 8 weeks. Curd cheese is consumed at breakfast and integrated into the participants' regular meal plans. The diet is balanced for total energy and macronutrient distribution according to individual nutritional needs. All participants in this arm receive the same type and brand of curd cheese throughout the intervention period.
Inget ingripande: Standard Diet Group
Participants in this arm follow a standard dietary plan for 8 weeks without curd cheese. The diet is balanced according to individual energy and macronutrient needs. This arm serves as a comparison group to determine the specific effects of curd cheese supplementation observed in the intervention group.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in HbA1c Levels
Tidsram: Baseline and after 8 weeks of intervention
To evaluate the effect of a curd cheese-supplemented diet on glycemic control by assessing changes in HbA1c levels from baseline to the end of the 8-week intervention.
Baseline and after 8 weeks of intervention

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Fasting Glucose
Tidsram: Baseline and after 8 weeks
To assess short-term glycemic response by measuring fasting blood glucose at baseline and after the 8-week intervention.
Baseline and after 8 weeks
Change in Lipid Profile
Tidsram: Baseline and after 8 weeks
To evaluate the effect of curd cheese supplementation on lipid metabolism by assessing changes in total cholesterol, LDL, HDL, and triglycerides from baseline to the end of the intervention.
Baseline and after 8 weeks
Change in Anthropometric Measures
Tidsram: Baseline and after 8 weeks
To evaluate changes in body mass index (BMI) from the start to the end of the intervention.
Baseline and after 8 weeks
Change in Anthropometric Measures
Tidsram: Baseline and after 8 weeks
To assess changes in body weight from baseline to the end of the intervention.
Baseline and after 8 weeks
Change in Anthropometric Measures
Tidsram: Baseline and after 8 weeks
To evaluate changes in body fat percentage from the beginning to the end of the intervention.
Baseline and after 8 weeks
Change in Anthropometric Measures
Tidsram: Baseline and after 8 weeks
To assess changes in waist circumference from the beginning to the end of the intervention.
Baseline and after 8 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Süleyman Kılıç

Samarbetspartners

Halic University

Utredare

  • Huvudutredare: Ahmet M GÜNAL, PhD, RD, Halic University
  • Studierektor: Salim YILMAZ, PhD, Acıbadem Mehmet Ali Aydınlar University

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

12 december 2025

Primärt slutförande (Faktisk)

22 maj 2026

Avslutad studie (Faktisk)

16 juni 2026

Studieregistreringsdatum

Först inskickad

16 juni 2026

Först inskickad som uppfyllde QC-kriterierna

27 juni 2026

Första postat (Faktisk)

30 juni 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

30 juni 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

27 juni 2026

Senast verifierad

1 juni 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • OkanU-KO-3

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data (IPD) will not be shared outside the research team to ensure participant privacy and confidentiality.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera